Evidence map›Paper›PMID 35893874›Full record

ArticleNutrients2022

Synergistic Effect of β-Lapachone and Aminooxyacetic Acid on Central Metabolism in Breast Cancer.

Mario C Chang, Rohit Mahar, Marc A McLeod, Anthony G Giacalone, Xiumei Huang, David A Boothman, Matthew E Merritt

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mario C ChangDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.ORCID 0000-0002-2452-2693
Rohit MaharDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.ORCID 0000-0002-9801-4173
Marc A McLeodDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Anthony G GiacaloneDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.
Xiumei HuangDepartment of Radiation Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0002-7306-0288
David A BoothmanDepartment of Radiation Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Matthew E MerrittDepartment of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, FL 32610, USA.ORCID 0000-0003-4617-9651
University of Florida · USIndiana University Health · US

Funding

TR&D3-SCHP41GM122698 · NIGMS · FLORIDA STATE UNIVERSITY · PI BREY, WILLIAM W, CROSS, TIMOTHY A · 2017 to 2021
$6.7M
Imaging Hepatic Energy Metabolism in NAFLD/NASHR01DK132254 · NIDDK · UNIVERSITY OF FLORIDA · PI MERRITT, MATTHEW E · 2022 to 2025
$2.0M
Tumor-selective use of PARP inhibitors against NQO1+ nonsmall cell lung cancerR01CA221158 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HUANG, XIUMEI, MOTEA, EDWARD AYSON · 2017 to 2022
$1.9M
Web Portal CoreU2CDK119889 · NIDDK · UNIVERSITY OF FLORIDA · PI YOST, RICHARD A. · 2018 to 2021
$1.9M
Tumor-selective radiosensitization of NSCLC using NQO1 bioactivatable drugsR01CA224493 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI HUANG, XIUMEI · 2018 to 2022
$1.8M
Imaging Hepatic Gluconeogenesis with Hyperpolarized DihydroxyacetoneR01DK105346 · NIDDK · UNIVERSITY OF FLORIDA · PI MERRITT, MATTHEW E · 2016 to 2020
$1.7M
NCI NIH HHS R01 CA221158NCI NIH HHS R01 CA224493NIDDK NIH HHS R01 DK105346NIDDK NIH HHS R01 DK132254NIDDK NIH HHS U2C DK119889NIGMS NIH HHS P41 GM122698
6 · The paper itself

Abstract

The compound β-lapachone, a naturally derived naphthoquinone, has been utilized as a potent medicinal nutrient to improve health. Over the last twelve years, numerous reports have demonstrated distinct associations of β-lapachone and NAD(P)H: quinone oxidoreductase 1 (NQO1) protein in the amelioration of various diseases. Comprehensive research of NQO1 bioactivity has clearly confirmed the tumoricidal effects of β-lapachone action through NAD

Indexed as

Aminooxyacetic AcidBreast NeoplasmsNaphthoquinonesCell Line, TumorCitratesFemaleGlutamatesHumansNADNAD(P)H Dehydrogenase (Quinone)SuccinatesAminooxyacetic Acidbeta-lapachoneCitratesGlutamatesNADNAD(P)H Dehydrogenase (Quinone)NaphthoquinonesSuccinatesbiogeniccancerGC-MSisotopologuemetabolismsynergy

Identifiers

PMID35893874
PMCPMC9331106
OpenAlexW4287149239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.